GPRIN1 and breast cancer: The existing research revealed that LINC02298 might be involved in the upstream regulation of GPRIN1 and associated with the detrimental outcome of kidney renal papillary cell carcinoma and LUAD (89), while AP000851.2 may have an impact on stemness regulation in breast cancer (90).